INCY

Nasdaq

INCYTE CORP

Health Care, Biotechnology

$120.56

close 7 Aug 2026

+52.24%

52-week change

$24.11B

market cap

$78.20

$132.60

52-week range

Valuation

Market cap$24.11B

P/E (TTM / 5y avg)17.03x95.19x

Forward P/E (FY2026 / FY2027)33.91x13.57x

PEG (TTM / fwd)0.280.23

P/S (TTM)4.50x

P/B4.29x

EV/EBITDA (TTM)—

FCF yield (TTM)6.02%

Cash flow & dividend

FCF (TTM)$1.45B

FCF per share (TTM)$7.26

FCF margin (TTM)27.06%

Dividend yield (indicated / 5y avg)——

Annualized dividend—

Payout ratio (EPS / FCF)——

Growth & quality

Revenue YoY, latest Q+20.87%

Diluted EPS YoY, latest Q+83.75%

Operating margin (TTM)30.05%

Net margin (TTM)26.71%

ROE (latest FY)24.90%

Net debt / EBITDA (TTM)—

Interest coverage (TTM)689.26

Price

+64.09%+10.45%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +14.03%10Y CAGR +21.17%

Diluted EPS

10Y CAGR +70.99%

FCF per share

10Y CAGR +36.93%

Operating cash flow

10Y CAGR +31.79%

Free cash flow

10Y CAGR +35.82%

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -1.99%10Y CAGR +0.62%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date26 Oct 2026

EPS estimate-$2.90

Revenue estimate$1.50B

Last reported

Date—

EPS——

Revenue——